Viewing Study NCT06847867


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-03-04 @ 1:06 AM
Study NCT ID: NCT06847867
Status: RECRUITING
Last Update Posted: 2025-06-27
First Post: 2025-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module